Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Array Biopharma Inc (ARRY)

Array Biopharma Inc (ARRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,676,721
  • Shares Outstanding, K 223,129
  • Annual Sales, $ 173,770 K
  • Annual Income, $ -147,350 K
  • 60-Month Beta 1.70
  • Price/Sales 42.87
  • Price/Cash Flow N/A
  • Price/Book 35.18
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.58
  • Most Recent Earnings -0.17 on 05/07/19
  • Next Earnings Date 08/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.16
  • Number of Estimates 8
  • High Estimate -0.11
  • Low Estimate -0.21
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.20 +3.57%
on 07/01/19
47.98 -0.27%
on 07/29/19
+1.52 (+3.28%)
since 06/28/19
3-Month
20.72 +130.94%
on 05/13/19
47.98 -0.27%
on 07/29/19
+25.24 (+111.63%)
since 04/30/19
52-Week
12.56 +280.97%
on 10/11/18
47.98 -0.27%
on 07/29/19
+32.98 (+221.79%)
since 07/30/18

Most Recent Stories

More News
Array Biopharma Has Returned 96.3% Since SmarTrend Recommendation (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 6 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)
Uptrend Call Working As Array Biopharma Stock Rises 96.3% (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 5 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)
Array Biopharma Has Returned 96.3% Since SmarTrend Recommendation (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 5 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)
96.3% Return Seen to Date on SmarTrend Array Biopharma Call (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 5 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)
Array Biopharma Shares Up 96.3% Since SmarTrend's Buy Recommendation (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 5 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)
96.3% Return Seen to Date on SmarTrend Array Biopharma Call (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 4 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)
OnKure Expands Executive Team and Appoints Head of Discovery, Chief Financial Officer and General Counsel

OnKure, Inc. today announced the appointment of three key members to its management team, James Winkler, Ph.D. as Vice President of Discovery and Translational Biology, R. Michael Carruthers as Chief Financial...

GSK : 44.26 (-0.36%)
NVLS : 2.40 (+2.13%)
ARRY : 47.85 (unch)
Array Biopharma Shares Up 96.3% Since SmarTrend's Buy Recommendation (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 4 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)
Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio

Pfizer Inc. (NYSE: PFE) is presenting data across its industry-leading oncology portfolio, including company-sponsored and collaborative research studies, spanning 11 therapies in 22 types of cancer, at...

ARRY : 47.85 (unch)
PFE : 36.93 (-0.32%)
96.3% Return Seen to Date on SmarTrend Array Biopharma Call (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 4 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

ARRY : 47.85 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ARRY with:

Business Summary

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory...

See More

Key Turning Points

2nd Resistance Point 47.85
1st Resistance Point 47.85
Last Price 47.85
1st Support Level 47.85
2nd Support Level 47.85

See More

52-Week High 47.98
Last Price 47.85
Fibonacci 61.8% 34.45
Fibonacci 50% 30.27
Fibonacci 38.2% 26.09
52-Week Low 12.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar